Table 2.

Summary of different types of statin treatments in type 2 diabetes patients (T2D) and patients without diabetes (No T2D)

	All	No T2D (n = 129)	T2D (n = 71)
Simvastatin, n (high/intermediate/low dose)	137 (76/52/9)	88 (44/37/7)	49 (32/15/2)
Pravastatin, n (high/intermediate/low dose)	7 (4/3/0)	5 (2/3/0)	2 (2/3/0)
Atorvastatin, n (high/intermediate/low dose)	16 (2/4/10)	7 (1/3/3)	9 (1/1/7)
Rosuvastatin, n (high/intermediate/low dose)	4 (1/1/2)	0 (0/0/0)	4 (1/1/2)

Statin treatments were divided into low, intermediate or high dose accordingly: Simvastatin (10 mg, 20–30 mg, 40 mg), Pravastatin (10 mg, 20 mg, 40 mg), Atorvastatin (10–30 mg, 40 mg, 80 mg) and Rosuvastatin (5–10 mg,  > 10–20 mg,  > 20–40 mg)